Breaking Finance News

DA Davidson disclosed Medifast (NYSE:MED), stepping up its target to $74.00 earlier today

Yesterday Medifast (NYSE:MED) traded 1.22% higher at $54.83. The company’s 50-day moving average is $51.35 and its 200-day moving average is $45.24. The last closing price is up 22.66% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time period. 41,190 shares of the stock traded hands, down from an average trading volume of 99,761

DA Davidson bumped up the target of Medifast (NYSE:MED) to $74.00 indicating a possible upside of 0.35%.

See Chart Below

Medifast (NYSE:MED)

Medifast has a 52 week low of $36.41 and a 52 week high of $56.70 with a P/E ratio of 27.88 The company’s market cap is currently $0.

General Information About Medifast (NYSE:MED)

Medifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. The Company provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians. The Company offers a range of weight loss, weight management and healthy products under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home and Essential 1 brands. The Company also offers a sports nutrition pilot product line, Dual Fuel.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.